The intradermal injection of a suspension of heatkilled mycobacteria in oil (Freund's adjuvant) produces in the rat a generalized disease, adjuvant arthritis or adjuvant disease (Pearson and Wood, 1959) . This can be transferred to syngeneic recipients with lymphoid cells from adjuvant-injected donors but not with serum (Waksman and Wennersten, 1963 ; Pearson and Wood, 1964a; Quagliata and Phillips -Quagliata, 1972) and is therefore considered to be a manifestation of delayed-type or cellular hypersensitivity to disseminated component(s) of the mycobacterium (Quagliata and Phillips-Quagliata, 1972) . In addition, the inflammatory reaction at the site of adjuvant injection provides a useful experimental model for the study of inflammation (Perper, Alvarez, Schroder, and Colombo, 1971) .
Antilymphocyte serum (ALS), among its many immunosuppressive properties, has been shown to suppress adjuvant disease (Currey and Ziff, 1968) . Another property of ALS is that it stimulates the transformation of lymphocytes into large blast-like cells capable of mitosis (Woodruff, Reid, and James, 1967) . Streptococcal culture filtrates have recently been shown to have a similar effect on lymphocytes (Taranta, Cuppari, and Quagliata, 1969; Taranta and Cuppari, 1970) ; we therefore thought it might be of interest to investigate the effect of such filtrates on adjuvant disease. Cellular components of Gramnegative bacteria have previously been shown to prevent adjuvant disease if injected in incomplete adjuvant, but not in saline, before the eliciting adjuvant injection (Wood and Pearson, 1962) .
We report that some preparations of Grampositive as well as Gram-negative bacterial extracellular products injected subcutaneously (s.c.) in saline starting the day before the adjuvant injection markedly suppress adjuvant disease.
Material and methods
Male Fisher 344 rats (215-230 g) were obtained from Microbiological Associates, Bethesda, Md, and maintained on a standard pellet and water ration ad libitum.
Adjuvant disease was induced as previously described (Quagliata, Sanders, and Gardner, 1969) .
All the rats were weighed immediately before the first injection of the various preparations used and then again as indicated. Bacterial and control preparations were given subcutaneously in 1 ml. doses.
The inflammatory reaction in the paws was assessed according to a commonly accepted 4-point scale as previously described (Quagliata and others, 1969) .
Haematocrit, haemoglobin, and red and white blood cell counts, were determined by standard methods.
Differential Each microbial strain was grown overnight in 500 ml. of Todd-Hewitt (TH) broth (Difco Labs., Detroit, Michigan), which were then inoculated into 4-5 1. of pre-warmed TH broth. After 6 hours' incubation the cultures were centrifuged at 4°C. for 30 min. at 7,970 G. An aliquot of each bacterial culture was sterilized by filtration through a Nalgene filter (pores 0-2 ,u) and tested for mitogenic activity undiluted and in 1/30, 1/900, 1/27,000, and 1/810,000 dilutions on cultures of human peripheral blood lymphocytes; the mitogenic activity was assayed morphologically as previously described (Taranta and others, 1969) . The Strep. pyogenes filtrate caused 50 per cent. transformation at an interpolated dilution of 1: 500. None of the other bacterial filtrates induced a transformation of 50 per cent. or greater at any of the dilutions tested (Taranta and Cuppari, unpublished observation) . The supematants and the uninoculated TH broth used as a control were concentrated by pervaporation at room temperature for 18 hrs, dialysed against cold tap-water for 6 hrs and against cold distilled water for 42 hrs. The dialysed materials were then re-concentrated by pervaporation at room temperature to a volume of 100 ml. and again dialysed in the cold against phosphate-buffered saline for 42 hrs. They were then centrifuged at 7,970 G. for 20 mi. and filtered through Nalgene filters, after which cultures were negative.
Human serum was obtained from two commercial blood donors. 5x crystallized ovalbumin (Pentex, Inc., Kankakee, Illinois) was prepared as a 30 mg./ml. solution.
The protein content of the preparations was determined as tyrosine residues by the Lowry method (Lowry, Rosebrough, Farr, and Randall, 1951) We tested the effect of two schedules of injections of Strep. pyogenes preparation A on the development of adjuvant disease. Thirty rats were divided into three groups of ten each. The control group was treated with twenty daily injections of 1 ml. sterile pyrogenfree 0 9 per cent. sodium chloride (saline), starting the day preceding the adjuvant injection. A second group was injected for the same period with 1 ml. of the Strep. pyogenes preparation and a third group was injected with the same preparation for 10 days, starting 4 days after the adjuvant injection. The inflammation score for the three groups was recorded until the 90th day after the adjuvant injection, as indicated in Fig. 1 for immunization and to a 1 per cent. suspension for a varying degree, the extra-articular manifestations of haemagglutination determinations, which were carried the disease such as blepharitis, urethritis, and subout as described (Levine and Levytska, 1967 Fig. 2 . As can be seen in Fig. 3 (opposite), preparation B was at least as effective as preparation A both in delaying the onset of swelling in the injected paw and in suppressing arthritis in the uninjected paws.
Although there was an initial weight loss in both groups, a second phase of weight loss occurred only in the controls, coincident with the appearance of arthritis.
WBC, RBC, and differential counts, determined 21 and 48 days after the adjuvant injection, are given in Table II (opposite). On Day 21 the controls had marked leucocytosis and moderate anaemia as compared to the rats injected with the Strep. pyogenes preparation. By Day 48 the RBC count of the controls had returned to normal, while that of Strep. pyogenestreated rats was slightly lower. The WBC count had decreased in the controls and in the Strep. pyogenestreated rats-but was definitely lower in the latter. The differential counts were very similar in both groups.
As in the previous experiments, extra-articular manifestations appeared in the controls but not in the rats injected with the Strep. pyogenes preparation, and the general state of health appeared to be better in the latter, as the weight curve clearly shows (Fig. 3) . THIRD 
EXPERIMENT
This was designed first to exclude the possibility that the suppression of the disease was merely due to the medium in which the streptococci had been grown, or to antigenic competition, and secondly to investigate the specificity of the phenomenon in terms of the bacterial species involved.
37 rats were divided into eight groups and injected daily for 20 days, starting the day before the adjuvant injection, as follows: antibody titre determinations 1 and 7 weeks later. Fig. 4 (overleaf) shows the result of this experiment.
In the groups receiving injections of saline or nonbacterial preparations, the swelling of the adjuvant injected paw followed the pattern previously observed in the controls. The swelling of the adjuvant-injected paw was initially decreased in each of the groups of rats receiving preparations of bacterial filtrates. This early local reaction was reduced most markedly in the groups injected with the Strep. pyogenes and with the S. typhimurium preparations.
The arthritis in the three uninjected paws was suppressed to a variable extent by the preparations used. Suppression and delay were greatest with the S. typhimurium and the Strep. pyogenes Table IV summarizes the haemagglutination data. One week after immunization with SRBC, the only significant reduction in the anti-SRBC titre, as compared with the saline-treated controls, was observed in the group treated with the S. typhimurium preparation. 6 weeks after immunization no significant differences were observed.
Discussion
The development of adjuvant disease presumably depends on the integrity of both immunological and inflammatory mechanisms. Predominantly antiinflammatory drugs, such as cortisone, suppress the manifestations of the disease for as long as they are administered, but shortly after their administration is stopped the disease manifests itself (Newbould, 1963) . Immunosuppressive agents, on the other hand, may suppress the disease permanently (reviewed by Quagliata and others, 1969) . The local reaction which occurs soon after the adjuvant injection depends mainly on inflammatory mechanisms (Perper and others, 1971) . The suppression of adjuvant disease, particularly with the Strep. pyogenes and S. typhimurium preparations, appeared to affect both inflammatory and immune responses: the local early reaction at the site of the adjuvant injection was decreased, and the arthritis in the uninjected paws was not only delayed but suppressed, i.e. its intensity was decreased ifand when it appeared.
It is probable that the mechanisms involved in the suppression of adjuvant arthritis are not the same for the preparations of extracellular products of Grampositive and Gram-negative bacteria. Only the rats injected with the Gram-negative bacterial preparation developed a marked leucopenia (see Table III ); this could well have interfered with the inflammatory and the immune response. That micro-organisms may produce substances which interfere with the inflammatory response is not, of course, a novel idea. Levaditi (1918) may have been the first to report an in vitro correlate of this interference-the ability of some streptococcal strains to kill leucocytes when engulfed by them. With a few exceptions (Malakian and Schwab, 1968, 1971; Hanna and Watson, 1968) , the ability of micro-organisms to interfere with immune mechanisms does not appear to have been studied, although both streptococci and staphylococci are known to produce substances capable of reacting with human lymphocytes (Taranta and others, 1969; Ling, Spicer, James, and Williamson, 1965) . Immunosuppression with a streptococcal preparation which differs from ours in being of cellular rather than extracellular origin (Malakian and Schwab, 1968, 1971 ) has been reported. Immunosuppression with preparations of streptococcal pyrogenic exotoxin (Hanna and Watson, 1968) has also been reported. Whether this toxin is the mediator of the effect we have described remains to be determined as far as the Strep. pyogenes preparations are concerned. It cannot, of course, be the mediator of the effect observed with the Strep. pneumoniae or S. typhimurium preparations, since neither ofthese organisms is known to produce streptococcal pyrogenic exotoxin or any toxin closely related to it.
The possibility that the inhibitory effect of the Strep. pyogenes preparations might be due to the streptococcal mitogen known to be present in them (Taranta and others, 1969; Taranta and Cuppari, 1970) deserves consideration, since other substances capable of inducing lymphocyte transformation, notably ALS, are immunosuppressive. Again, however, the arthritis inhibitory effect of the Strep. pneumoniae and S. typhimurium preparations cannot be explained on this basis, since these species are known not to produce extracellular substances comparable to the streptococcal and staphylococcal mitogens (Taranta and Cuppari, 1970 ) and the particular strains tested were not exceptions (Taranta and Cuppari, unpublished observations) .
The possibility that the suppression of adjuvant disease by extracellular bacterial products is the result of antigenic competition (Wood and Pearson, 1962; Gery and Waksman, 1967; Pearson and Wood, 1964b) was considered: therefore two additional controls were included in the third experiment, one (crystalline ovalbumin) consisting essentially of a single protein and the other (human serum) consisting of about as many proteins as are present in the Strep. pyogenes culture filtrate. Neither of these control preparations provided a reduction of the disease of the degree obtained with the active bacterial products-thus failing to support the hypothesis of antigenic competition as the only or main mechanism of the suppression of adjuvant disease obtained with the bacterial products.
It should be noted that the maximum suppression obtained (in S. typhimurium and Strep. pyogenestreated rats) was quantitatively similar to that reported by others and by one of us with ALS and other powerful disruptors of immune mechanisms (Currey and Ziff, 1968; Quagliata and others, 1969; Quagliata, Phillips-Quagliata, and Floersheim, 1972; Zurier and Quagliata, 1971) . Therefore, further study of this suppression and definition of the extracellular bacterial products involved may be rewarding in terms of experimental pathology and therapeutics. Summary Both the inflammatory response at the site ofadjuvant injection and the subsequent development ofadjuvant disease in the rat were markedly suppressed by the administration of extracellular products from some bacterial species. Salmonella typhimurium products caused marked leucopenia, inhibition of circulating antibody response, and suppression of adjuvant disease. Strep. pyogenes products did not cause leucopenia or inhibition of circulating antibody response, yet they caused marked inhibition of adjuvant disease. Strep. pneumoniae products had similar, but less marked effects, while Staph. aureus products were ineffective. 
